Abstract
Autosomal recessive polycystic kidney disease (ARPKD), is a rare hepatorenal fibrocystic disorder primarily associated with progressive growth of multiple cysts in the kidneys causing progressive loss of renal function. The disease is linked to mutations in the PKHD1 gene. In this study, we describe the gene diagnosis and prenatal diagnosis for a consanguineous family with two fetuses diagnosed with polycystic kidney disease by fetal sonography during the pregnancy. Sequence analysis of cDNA synthesized from the PKHD1 mRNA of the second induced fetus identified a 111-nucleotide insert at the junction of exon 56 and 57 that originated from intervening sequence (IVS) 56. Further genomic sequencing of IVS 56 of the PKHD1 gene identified a rare homozygous deep intronic mutation (c.8798-459 C > A), which was inherited from the parents and not detectable in 100 unrelated control subjects. Moreover, we explored the pathogenicity of this deep intronic mutation by conducting a minigene splicing assay experiment, which demonstrated that the mutation causes a pseudoexon insertion, which results in a frameshift followed by a premature termination codon in exon 57. Eventually, the parents had a healthy baby by undergoing prenatal genetic diagnosis based on the targeted detection of the intron mutation. The newly identified deep intronic mutation is associated with a rare mechanism of abnormal splicing that expands the spectrum of known PKHD1 gene mutations. It can be used in evidence-based genetic and reproductive counseling for families with ARPKD.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Harris PC, Torres VE. Polycystic kidney disease. Annu Rev Med. 2009;60:321–37.
Sweeney WE, Avner ED. Polycystic kidney disease autosomal recessive. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews®. Seattle (WA): University of Washington, Seattle;1993. Seattle, WA; 1993.
Losekoot M, Haarloo C, Ruivenkamp C, White SJ, Breuning MH, Peters DJ. Analysis of missense variants in the PKHD1-gene in patients with autosomal recessive polycystic kidney disease (ARPKD). Hum Genet. 2005;118(2):185–206.
Zerres K, Senderek J, Rudnik-Schoneborn S, Eggermann T, Kunze J, Mononen T, et al. New options for prenatal diagnosis in autosomal recessive polycystic kidney disease by mutation analysis of the PKHD1 gene. Clin Genet. 2004;66(1):53–7.
Bergmann C, Frank V, Kupper F, Schmidt C, Senderek J, Zerres K. Functional analysis of PKHD1 splicing in autosomal recessive polycystic kidney disease. J Hum Genet. 2006;51(9):788–93.
Denamur E, Delezoide AL, Alberti C, Bourillon A, Gubler MC, Bouvier R, et al. Genotype-phenotype correlations in fetuses and neonates with autosomal recessive polycystic kidney disease. Kidney Int. 2010;77(4):350–8.
Wehrman A, Kriegermeier A, Wen J. Diagnosis and management of hepatobiliary complications in autosomal recessive polycystic kidney disease. Front Pediatr . 2017;5:124.
Edrees BM, Athar M, Abduljaleel Z, Al-Allaf FA, Taher MM, Khan W, et al. Functional alterations due to amino acid changes and evolutionary comparative analysis of ARPKD and ADPKD genes. Genom Data. 2016;10:127–34.
Anderson K, Moore MJ. Bimolecular exon ligation by the human spliceosome. Science . 1997;276(5319):1712–6.
Stepensky P, Keller B, Shamriz O, NaserEddin A, Rumman N, Weintraub M, et al. Deep intronic mis-splicing mutation in JAK3 gene underlies T-B+NK- severe combined immunodeficiency phenotype. Clin Immunol. 2016;163:91–5.
Anczukow O, Buisson M, Leone M, Coutanson C, Lasset C, Calender A, et al. BRCA2 deep intronic mutation causing activation of a cryptic exon: opening toward a new preventive therapeutic strategy. Clin Cancer Res. 2012;18(18):4903–9.
Liquori A, Vache C, Baux D, Blanchet C, Hamel C, Malcolm S, et al. Whole USH2A gene sequencing identifies several new deep intronic mutations. Hum Mutat. 2016;37(2):184–93.
Giorgi G, Casarin A, Trevisson E, Dona M, Cassina M, Graziano C, et al. Validation of CFTR intronic variants identified during cystic fibrosis population screening by a minigene splicing assay. Clin Chem Lab Med. 2015;53(11):1719–23.
Naruto T, Okamoto N, Masuda K, Endo T, Hatsukawa Y, Kohmoto T, et al. Deep intronic GPR143 mutation in a Japanese family with ocular albinism. Sci Rep. 2015;5:11334.
Michel-Calemard L, Dijoud F, Till M, Lambert JC, Vercherat M, Tardy V, et al. Pseudoexon activation in the PKHD1 gene: a French founder intronic mutation IVS46+653A>G causing severe autosomal recessive polycystic kidney disease. Clin Genet. 2009;75(2):203–6.
Onuchic LF, Furu L, Nagasawa Y, Hou X, Eggermann T, Ren Z, et al. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am J Hum Genet. 2002;70(5):1305–17.
Vaz-Drago R, Custodio N, Carmo-Fonseca M. Deep intronic mutations and human disease. Hum Genet. 2017;136(9):1093–111.
Spena S, Asselta R, Plate M, Castaman G, Duga S, Tenchini ML. Pseudo-exon activation caused by a deep-intronic mutation in the fibrinogen gamma-chain gene as a novel mechanism for congenital afibrinogenaemia. Br J Haematol. 2007;139(1):128–32.
Tan J, Ho JX, Zhong Z, Luo S, Chen G, Roca X. Noncanonical registers and base pairs in human 5’ splice-site selection. Nucleic Acids Res. 2016;44(8):3908–21.
Acknowledgements
The authors are grateful to the patients and their family members for participating in this study; the professor Zhengzhen Zhou at Department of pathology of Hunan Children’s Hospital for providing histological analysis of the renal tissues from the second fetus postmortem. This study was supported by a grant from the National Key Research & Developmental Program of China (2018YFC1004900).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Chen, J., Ma, N., Zhao, X. et al. A rare deep intronic mutation of PKHD1 gene, c.8798-459 C > A, causes autosomal recessive polycystic kidney disease by pseudoexon activation. J Hum Genet 64, 207–214 (2019). https://doi.org/10.1038/s10038-018-0550-8
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s10038-018-0550-8
This article is cited by
-
The impact of consanguinity on human health and disease with an emphasis on rare diseases
Journal of Rare Diseases (2022)
-
Possible PKHD1 Hot-spot Mutations Related to Early Kidney Function Failure or Hepatofibrosis in Chinese Children with ARPKD: A Retrospective Single Center Cohort Study and Literature Review
Current Medical Science (2020)
